UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 377

Sortiert nach

Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

JACC. Heart failure, 2017-08, Vol.5 (8), p.565-574

2017

Link zum Volltext

Verfügbarkeit prüfen

Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry

European journal of heart failure, 2014-02, Vol.16 (2), p.173-179

2014

Link zum Volltext

Verfügbarkeit prüfen

Association between demographic, organizational, clinical, and socio‐economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry

European journal of heart failure, 2017-10, Vol.19 (10), p.1270-1279

2017

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens

International journal of cardiology, 2013-09, Vol.167 (5), p.1860-1866

2013

Link zum Volltext

Verfügbarkeit prüfen

Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid‐range, and reduced ejection fraction

European journal of heart failure, 2017-12, Vol.19 (12), p.1606-1614

2017

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry

PLoS medicine, 2018-03, Vol.15 (3), p.e1002540-e1002540

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

European journal of heart failure, 2016-05, Vol.18 (5), p.503-511

2016

Link zum Volltext

Verfügbarkeit prüfen

Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction

JAMA : the journal of the American Medical Association, 2014-11, Vol.312 (19), p.2008

2014

Link zum Volltext

Verfügbarkeit prüfen

Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators

Journal of the American College of Cardiology, 2017-05, Vol.69 (21), p.2606-2618

2017

Link zum Volltext

Verfügbarkeit prüfen

Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey

European journal of heart failure, 2014-01, Vol.16 (1), p.103-111

2014

Link zum Volltext

Verfügbarkeit prüfen

Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction

Clinical research in cardiology, 2021-07, Vol.110 (7), p.1051-1062

2021

Link zum Volltext

Verfügbarkeit prüfen

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry

European journal of heart failure, 2018-09, Vol.20 (9), p.1326-1334

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata

European journal of heart failure, 2022-06, Vol.24 (6), p.1047-1062

2022

Link zum Volltext

Verfügbarkeit prüfen

Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study

European heart journal, 2018-12, Vol.39 (48), p.4257-4265

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry

Clinical research in cardiology, 2019-09, Vol.108 (9), p.1025-1033

2019

Link zum Volltext

Verfügbarkeit prüfen

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction

JAMA : the journal of the American Medical Association, 2012-11, Vol.308 (20), p.2108

2012

Link zum Volltext

Verfügbarkeit prüfen

Nurse-Led Heart Failure Clinics Are Associated With Reduced Mortality but Not Heart Failure Hospitalization

Journal of the American Heart Association, 2019-05, Vol.8 (10), p.e011737-e011737

2019

Link zum Volltext

Verfügbarkeit prüfen

Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score–Matched Analysis From the Swedish Heart Failure Registry

Circulation (New York, N.Y.), 2019-11, Vol.140 (19), p.1530-1539

2019

Link zum Volltext

Verfügbarkeit prüfen

Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry

European journal of heart failure, 2022-05, Vol.24 (5), p.871-884

2022

Link zum Volltext

Verfügbarkeit prüfen

Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure

JAMA : the journal of the American Medical Association, 2011-05, Vol.305 (20), p.2088

2011

Link zum Volltext

Verfügbarkeit prüfen

Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study

European heart journal, 2015-09, Vol.36 (34), p.2318-2326

2015

Link zum Volltext

Verfügbarkeit prüfen

The benefits of using a heart failure management programme in Swedish primary healthcare

European journal of heart failure, 2013-02, Vol.15 (2), p.228-236

2013

Link zum Volltext

Verfügbarkeit prüfen

The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure

Upsala journal of medical sciences, 2019, Vol.124 (1), p.65-69

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction

European journal of heart failure, 2019-04, Vol.21 (4), p.471-479

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 377

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(366)
Mit Volltextzugriff
(351)

Publikationsform

Sprache

Englisch
(355)
Japanisch
(32)
Schwedisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(260)
Life Sciences & Biomedicine
(259)
Humans
(221)
Cardiovascular System & Cardiology
(196)
Cardiac & Cardiovascular Systems
(190)
Heart Failure
(179)
Female
(163)
Male
(158)
Aged
(153)
Medicin Och Hälsovetenskap
(147)
Medicine
(113)
Medicin
(104)
Aged, 80 And Over
(103)
Middle Aged
(89)
Prognosis
(79)
Registries
(71)
Sweden - Epidemiology
(68)
Mortality
(61)
Heart Failure - Drug Therapy
(58)
Heart Failure - Epidemiology
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction

Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry

Association between demographic, organizational, clinical, and socio‐economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry

European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions

Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: A 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens

Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid‐range, and reduced ejection fraction

Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry

Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction

Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators

Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey

Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction

Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry

Use of evidence‐based therapy in heart failure with reduced ejection fraction across age strata

Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study

Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry

Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction

Nurse-Led Heart Failure Clinics Are Associated With Reduced Mortality but Not Heart Failure Hospitalization

Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score–Matched Analysis From the Swedish Heart Failure Registry

Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry

Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure

Association between renin-angiotensin system antagonist use and mortality in heart failure with severe renal insufficiency: a prospective propensity score-matched cohort study

The benefits of using a heart failure management programme in Swedish primary healthcare

The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure

Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction

Suchergebnisse filtern